Canaccord has lowered its price target for Tempus AI, Inc. (NASDAQ:TEM) from $95 to $80, while maintaining a 'buy' rating on the stock. Tempus AI is recognized as one of the top 12 genomics stocks to invest in, according to TheFly's report on December 22, 2025.